AVITA Medical(RCEL) - 2024 Q2 - Quarterly Results

Exhibit 99.1 AVITA Medical Reports Second Quarter Financial Results VALENCIA, Calif., August 8, 2024 — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the second quarter ended June 30, 2024. Financial Results and Recent Business Updates • Commercial revenue of $15.1 million, an increase of approximately 29% compared to the same period in 2023 • ...